Since 2020, the company has invested $23 billion overall in building facilities in the U.S., including a $1.7 billion factory in the Research Triangle Park area of North Carolina, which the company expects to become operational in 2027
However, components of obesity pathology -particularly IR and low-grade inflammation- may impair these protective mechanisms, thereby contributing to the development of SO
The most common side effects of Zepbound may include nausea, vomiting, diarrhea, constipation, abdominal pain, indigestion, and hair loss, especially when starting the medication or after a dose increase
Since then, several more GLP-1 agonists have been approved by the FDA
Tirzepatide updates from EASD Drs
Genetic variation in GLP-1 receptor sensitivity and appetite-regulation pathways may partially explain these differences